{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:49:53Z","timestamp":1769280593785,"version":"3.49.0"},"reference-count":73,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Juvenile Diabetes Research Foundation","award":["17-2013-403"],"award-info":[{"award-number":["17-2013-403"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK092480"],"award-info":[{"award-number":["DK092480"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Some immune system cells express type A and\/or type B \u03b3-aminobutyric acid receptors (GABAA-Rs and\/or GABAB-Rs). Treatment with GABA, which activates both GABAA-Rs and GABAB-Rs), and\/or a GABAA-R-specific agonist inhibits disease progression in mouse models of type 1 diabetes (T1D), multiple sclerosis, rheumatoid arthritis, and COVID-19. Little is known about the clinical potential of specifically modulating GABAB-Rs. Here, we tested lesogaberan, a peripherally restricted GABAB-R agonist, as an interventive therapy in diabetic NOD mice. Lesogaberan treatment temporarily restored normoglycemia in most newly diabetic NOD mice. Combined treatment with a suboptimal dose of lesogaberan and proinsulin\/alum immunization in newly diabetic NOD mice or a low-dose anti-CD3 in severely hyperglycemic NOD mice greatly increased T1D remission rates relative to each monotherapy. Mice receiving combined lesogaberan and anti-CD3 displayed improved glucose tolerance and, unlike mice that received anti-CD3 alone, had some islets with many insulin+ cells, suggesting that lesogaberan helped to rapidly inhibit \u03b2-cell destruction. Hence, GABAB-R-specific agonists may provide adjunct therapies for T1D. Finally, the analysis of microarray and RNA-Seq databases suggested that the expression of GABAB-Rs and GABAA-Rs, as well as GABA production\/secretion-related genes, may be a more common feature of immune cells than currently recognized.<\/jats:p>","DOI":"10.3390\/biomedicines9010043","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T09:15:16Z","timestamp":1609924516000},"page":"43","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["GABAB-Receptor Agonist-Based Immunotherapy for Type 1 Diabetes in NOD Mice"],"prefix":"10.3390","volume":"9","author":[{"given":"Jide","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake","family":"Middleton","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Seunghee","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Won","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bokyoung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0283-3749","authenticated-orcid":false,"given":"Ryan S.","family":"Beyer","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah W.","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis","family":"Mai","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Anne","family":"O\u2019Laco","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Pharmacology, University of California, Los Angeles, CA 90095-1735, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: Subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0165-5728(98)00264-1","article-title":"GABA(A) receptors mediate inhibition of T cell responses","volume":"96","author":"Tian","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mendu, S.K., Bhandage, A., Jin, Z., and Birnir, B. (2012). Different subtypes of GABA-A receptors are expressed in human, mouse and rat T lymphocytes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042959"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/TP.0b013e31829c24be","article-title":"GABA protects human islet cells against the deleterious effects of immunosuppressive drugs and exerts immunoinhibitory effects alone","volume":"96","author":"Glinka","year":"2013","journal-title":"Transplantation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5298","DOI":"10.4049\/jimmunol.173.8.5298","article-title":"Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model","volume":"173","author":"Tian","year":"2004","journal-title":"J. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.03.019","article-title":"GABA Regulates Release of Inflammatory Cytokines From Peripheral Blood Mononuclear Cells and CD4(+) T Cells and Is Immunosuppressive in Type 1 Diabetes","volume":"30","author":"Bhandage","year":"2018","journal-title":"EBioMedicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.neuropharm.2010.11.007","article-title":"An intrinsic GABAergic system in human lymphocytes","volume":"60","author":"Dionisio","year":"2011","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Wheeler, D.W., Thompson, A.J., Corletto, F., Reckless, J., Loke, J.C., and Lapaque, N. (2011). Anaesthetic impairment of immune function is mediated via GABA(A) receptors. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017152"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jneuroim.2008.08.017","article-title":"GABA, a natural immunomodulator of T lymphocytes","volume":"205","author":"Bjurstom","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/08916934.2011.571223","article-title":"Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis","volume":"44","author":"Tian","year":"2011","journal-title":"Autoimmunity"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1073\/pnas.0915139107","article-title":"Inhibitory role for GABA in autoimmune inflammation","volume":"107","author":"Bhat","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1073\/pnas.1102715108","article-title":"GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes","volume":"108","author":"Soltani","year":"2011","journal-title":"Proc. Natl. Acad Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"16555","DOI":"10.1038\/s41598-018-32733-3","article-title":"Homotaurine, a safe blood-brain barrier permeable GABAA-R-specific agonist, ameliorates disease in mouse models of multiple sclerosis","volume":"8","author":"Tian","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/immunohorizons.1900019","article-title":"Homotaurine treatment enhances CD4+ and CD8+ Treg responses and synergizes with low-dose anti-CD3 to enhance diabetes remission in type 1 diabetic mice","volume":"3","author":"Tian","year":"2019","journal-title":"ImmuoHorizons"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Tian, J., Milddleton, B., and Kaufman, D.L. (2020). GABA administration prevents severe illness and death following coronavirus infection in mice. bioRxiv.","DOI":"10.1101\/2020.10.04.325423"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/jcp.24884","article-title":"The anti-spasticity drug baclofen alleviates collagen-induced arthritis and regulates dendritic cells","volume":"230","author":"Huang","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1600-0625.2010.01076.x","article-title":"Anti-inflammatory effects of the GABA(B) receptor agonist baclofen in allergic contact dermatitis","volume":"19","author":"Duthey","year":"2010","journal-title":"Exp. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00581047","article-title":"Baclofen, a gamma-aminobutyric acid-b receptor agonist, delays diabetes onset in the non-obese diabetic mouse","volume":"32","author":"Beales","year":"1995","journal-title":"Acta Diabetol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fncel.2015.00284","article-title":"Modulation of TLR3\/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: Relevance to therapeutic effects in multiple sclerosis","volume":"9","author":"Crowley","year":"2015","journal-title":"Front. Cell Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0024-3205(93)90229-V","article-title":"Suppressive effect of GABA on insulin secretion from the pancreatic beta-cells in the rat","volume":"52","author":"Gu","year":"1993","journal-title":"Life Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/341233a0","article-title":"Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels","volume":"341","author":"Rorsman","year":"1989","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.2337\/db09-0797","article-title":"Gamma-aminobutyric acid (GABA) is an autocrine excitatory transmitter in human pancreatic beta-cells","volume":"59","author":"Braun","year":"2010","journal-title":"Diabetes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1085\/jgp.200308966","article-title":"Regulated exocytosis of GABA-containing synaptic-like microvesicles in pancreatic beta-cells","volume":"123","author":"Braun","year":"2004","journal-title":"J. Gen. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1007\/s00125-012-2548-7","article-title":"Gamma-Aminobutyric acid (GABA) signalling in human pancreatic islets is altered in type 2 diabetes","volume":"55","author":"Taneera","year":"2012","journal-title":"Diabetologia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00125-001-0750-0","article-title":"Metabotropic glutamate and GABA(B) receptors contribute to the modulation of glucose-stimulated insulin secretion in pancreatic beta cells","volume":"45","author":"Brice","year":"2002","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.2337\/db13-0931","article-title":"gamma-Aminobutyric acid regulates both the survival and replication of human beta-cells","volume":"62","author":"Tian","year":"2013","journal-title":"Diabetes"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.2337\/db14-0153","article-title":"GABA promotes human beta-cell proliferation and modulates glucose homeostasis","volume":"63","author":"Purwana","year":"2014","journal-title":"Diabetes"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000118451","article-title":"Decreased central GABA B receptor binding sites in diabetic rats","volume":"19","author":"Martin","year":"1988","journal-title":"Neuropsychobiology"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tian, J., and Dang, H. (2011). Combining Antigen-Based Therapy with GABA Treatment Synergistically Prolongs Survival of Transplanted \u00df-Cells in Diabetic NOD Mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025337"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1124\/jpet.109.153593","article-title":"(R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action","volume":"331","author":"Lehmann","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1136\/gutjnl-2012-302737","article-title":"Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: A randomised controlled trial","volume":"62","author":"Shaheen","year":"2013","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1021\/jm701425k","article-title":"Synthesis and pharmacological evaluation of novel gamma-aminobutyric acid type B (GABAB) receptor agonists as gastroesophageal reflux inhibitors","volume":"51","author":"Alstermark","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/11590310-000000000-00000","article-title":"Pharmacokinetic profile of lesogaberan (AZD3355) in healthy subjects: A novel GABA(B)-receptor agonist reflux inhibitor","volume":"11","author":"Niazi","year":"2011","journal-title":"Drugs R D"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5414\/CP201587","article-title":"Effect of food on the bioavailability of lesogaberan given as an oral solution or as modified-release capsules in healthy male volunteers","volume":"50","author":"Fransson","year":"2012","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/j.gastro.2010.04.051","article-title":"Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease","volume":"139","author":"Boeckxstaens","year":"2010","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6403539","DOI":"10.1155\/2017\/6403539","article-title":"Repurposing Lesogaberan to Promote Human Islet Cell Survival and beta-Cell Replication","volume":"2017","author":"Tian","year":"2017","journal-title":"J. Diabetes Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.immuni.2005.08.002","article-title":"A comprehensive review of interventions in the NOD mouse and implications for translation","volume":"23","author":"Shoda","year":"2005","journal-title":"Immunity"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.2337\/db13-1385","article-title":"Combined therapy with GABA and proinsulin\/alum acts synergistically to restore long-term normoglycemia by modulating T-cell autoimmunity and promoting beta-cell replication in newly diabetic NOD mice","volume":"63","author":"Tian","year":"2014","journal-title":"Diabetes"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Fuks, J.M., Arrighi, R.B., Weidner, J.M., Kumar Mendu, S., Jin, Z., and Wallin, R.P. (2012). GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003051"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","article-title":"CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice","volume":"158","author":"Chatenoud","year":"1997","journal-title":"J. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/en.2007-0358","article-title":"Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells","volume":"148","author":"Sherry","year":"2007","journal-title":"Endocrinology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI27191","article-title":"Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs","volume":"116","author":"Bresson","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice","volume":"91","author":"Chatenoud","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0966-3274(02)00050-3","article-title":"Remission and pancreas isograft survival in recent onset diabetic NOD mice after treatment with low-dose anti-CD3 monoclonal antibodies","volume":"10","author":"Mottram","year":"2002","journal-title":"Transpl. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2011.12.013","article-title":"Effects of GABAB receptor agonists and antagonists on glycemia regulation in mice","volume":"677","author":"Bonaventura","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Tian, J., Dang, H.N., Yong, J., Chui, W.S., Dizon, M.P., and Yaw, C.K. (2011). Oral treatment with gamma-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025338"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/gut.2010.235630","article-title":"A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: A randomised placebo-controlled trial","volume":"60","author":"Boeckxstaens","year":"2011","journal-title":"Gut"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/11588180-000000000-00000","article-title":"Evaluation of the pharmacokinetic interaction between lesogaberan (AZD3355) and esomeprazole in healthy subjects","volume":"10","author":"Niazi","year":"2010","journal-title":"Drugs R D"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7242","DOI":"10.4049\/jimmunol.174.11.7242","article-title":"Gamma-amino butyric acid type B receptors stimulate neutrophil chemotaxis during ischemia-reperfusion","volume":"174","author":"Rane","year":"2005","journal-title":"J. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/386239a0","article-title":"Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors","volume":"386","author":"Kaupmann","year":"1997","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1006\/mcne.2001.0995","article-title":"Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice","volume":"17","author":"Prosser","year":"2001","journal-title":"Mol. Cell Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0896-6273(01)00345-2","article-title":"Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1))","volume":"31","author":"Schuler","year":"2001","journal-title":"Neuron"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1523\/JNEUROSCI.21-20-08043.2001","article-title":"GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer","volume":"21","author":"Robbins","year":"2001","journal-title":"J. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.celrep.2019.01.041","article-title":"RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell Types","volume":"26","author":"Monaco","year":"2019","journal-title":"Cell Rep."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0165-6147(98)01270-X","article-title":"Two isoforms of glutamate decarboxylase: Why?","volume":"19","author":"Soghomonian","year":"1998","journal-title":"Trends Pharmacol Sci."},{"key":"ref_60","first-page":"411","article-title":"On the role of GABA in vertebrate polyamine metabolism","volume":"12","author":"Seiler","year":"1980","journal-title":"Physiol. Chem. Phys."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0197-0186(87)90131-8","article-title":"GABA and its relationship to putrescine metabolism in the rat brain and pancreas","volume":"10","author":"Caron","year":"1987","journal-title":"Neurochem. Int."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1126\/science.1184334","article-title":"Channel-mediated tonic GABA release from glia","volume":"330","author":"Lee","year":"2010","journal-title":"Science"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5607\/en.2017.26.3.113","article-title":"Distribution and Function of the Bestrophin-1 (Best1) Channel in the Brain","volume":"26","author":"Oh","year":"2017","journal-title":"Exp. Neurobiol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Bhandage, A.K., Cunningham, J.L., Jin, Z., Shen, Q., Bongiovanni, S., and Korol, S.V. (2019). Depression, GABA, and Age Correlate with Plasma Levels of Inflammatory Markers. Int. J. Mol. Sci., 20.","DOI":"10.1101\/689984"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1016\/j.cellsig.2006.05.014","article-title":"Interactions between GABA-B1 receptors and Kir 3 inwardly rectifying potassium channels","volume":"18","author":"David","year":"2006","journal-title":"Cell Signal."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12031-008-9163-6","article-title":"GABA-B(1) receptors are coupled to the ERK1\/2 MAP kinase pathway in the absence of GABA-B(2) subunits","volume":"38","author":"Richer","year":"2009","journal-title":"J. Mol. Neurosci."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Baloucoune, G.A., Chun, L., Zhang, W., Xu, C., Huang, S., and Sun, Q. (2012). GABAB receptor subunit GB1 at the cell surface independently activates ERK1\/2 through IGF-1R transactivation. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039698"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.01.036","article-title":"GABAA receptor: Positive and negative allosteric modulators","volume":"136","author":"Olsen","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_69","first-page":"683","article-title":"Gamma-Aminobutyric acid A or C receptor? gamma-Aminobutyric acid rho 1 receptor RNA induces bicuculline-, barbiturate-, and benzodiazepine-insensitive gamma-aminobutyric acid responses in Xenopus oocytes","volume":"41","author":"Shimada","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0042-6989(97)00277-0","article-title":"Molecular composition of GABAC receptors","volume":"38","author":"Enz","year":"1998","journal-title":"Vis. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5783545","DOI":"10.1155\/2019\/5783545","article-title":"A Clinically Applicable Positive Allosteric Modulator of GABA Receptors Promotes Human beta-Cell Replication and Survival as well as GABA\u2019s Ability to Inhibit Inflammatory T Cells","volume":"2019","author":"Tian","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Bhandage, A.K., Olivera, G.C., Kanatani, S., Thompson, E., Lore, K., and Varas-Godoy, M. (2020). A motogenic GABAergic system of mononuclear phagocytes facilitates dissemination of coccidian parasites. eLife, 9.","DOI":"10.7554\/eLife.60528"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1523\/JNEUROSCI.14-09-05429.1994","article-title":"Few cell lines with GABAA mRNAs have functional receptors","volume":"14","author":"Hales","year":"1994","journal-title":"J. Neurosci."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/43\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:07:26Z","timestamp":1760159246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/1\/43"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1]]}},"alternative-id":["biomedicines9010043"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9010043","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]}}}